What are the AAN/AANEM treatment guidelines for congenital muscular dystrophy?

Updated: Aug 17, 2020
  • Author: Twee T Do, MD; Chief Editor: Jeffrey D Thomson, MD  more...
  • Print


The AAN/AANEM guidelines note that there are no curative CMD subtype-specific interventions. Thus, all screening and interventions are intended to promote growth and potential development, mitigate cumulative morbidities, optimize function, and limit mortality while maximizing quality of life.

At the time of diagnosis, the family should be informed regarding areas of uncertainty such as clinical outcomes and the value of interventions as they pertain to both longevity and quality of life. Physicians should explain the multisystem implications of neuromuscular insufficiency and guide families as they make decisions regarding the monitoring for and treatment of CMD complications (level B).

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!